Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.22.1
Income Taxes
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Income Tax

8. Income Taxes

The provision for income taxes consisted of the following for the periods presented:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Current provision (benefit):

 

 

 

 

 

 

 

 

 

Federal

 

$

 

 

$

(9,748

)

 

$

 

State

 

 

2,237

 

 

 

4,876

 

 

 

1,786

 

     Total current provision (benefit)

 

 

2,237

 

 

 

(4,872

)

 

 

1,786

 

Deferred (benefit) provision:

 

 

 

 

 

 

 

 

 

Federal

 

 

(22,781

)

 

 

20,774

 

 

 

(4,488

)

State

 

 

(4,549

)

 

 

866

 

 

 

66

 

Total deferred (benefit) provision

 

 

(27,330

)

 

 

21,640

 

 

 

(4,422

)

Total (benefit) provision

 

$

(25,093

)

 

$

16,768

 

 

$

(2,636

)

 

A reconciliation of the statutory income tax rate (benefit) provision to the Company’s (benefit) provision consisted of the following for the periods presented:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Income tax (benefit) provision at the statutory rate

 

$

(9,899

)

 

$

16,206

 

 

$

(360

)

Increase (decrease) resulting from:

 

 

 

 

 

 

 

 

 

Federal credits

 

 

(606

)

 

 

(400

)

 

 

(623

)

State income taxes, net of federal benefit

 

 

(2,903

)

 

 

4,813

 

 

 

1,691

 

Other nondeductible expenses

 

 

714

 

 

 

184

 

 

 

175

 

Valuation allowance adjustment

 

 

122

 

 

 

(95

)

 

 

(2,688

)

Stock based compensation

 

 

(12,494

)

 

 

(33

)

 

 

(851

)

Change in tax law (CARES Act)

 

 

 

 

 

(3,906

)

 

 

 

Other, net

 

 

(27

)

 

 

(1

)

 

 

20

 

Income tax (benefit) provision

 

$

(25,093

)

 

$

16,768

 

 

$

(2,636

)

 

 

 

 

As of

 

 

 

December 31, 2021

 

 

December 31, 2020

 

Deferred tax assets:

 

 

 

 

 

 

Lease liability

 

$

189,231

 

 

$

179,280

 

Stock based compensation

 

 

47,626

 

 

 

4,350

 

Accrued compensation costs

 

 

1,556

 

 

 

1,102

 

Deferred revenue

 

 

1,955

 

 

 

673

 

Net operating loss (NOL) carryforwards

 

 

27,971

 

 

 

14,289

 

Federal credit carryforward

 

 

3,578

 

 

 

2,650

 

Other

 

 

1,852

 

 

 

1,780

 

Gross deferred tax assets

 

 

273,769

 

 

 

204,124

 

   Less valuation allowance

 

 

(122

)

 

 

 

          Net deferred tax assets

 

 

273,647

 

 

 

204,124

 

 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

 

Right of use asset

 

 

(180,018

)

 

 

(169,972

)

Goodwill and other intangible assets

 

 

(46,254

)

 

 

(41,400

)

Property and equipment

 

 

(68,539

)

 

 

(38,602

)

Other

 

 

(1,439

)

 

 

(232

)

Gross deferred tax liabilities

 

 

(296,250

)

 

 

(250,206

)

Total deferred tax liabilities, net

 

$

(22,603

)

 

$

(46,082

)

 

The Company had a federal net operating loss ("NOL") carryforwards available of $125,740 at December 31, 2021, which can be carried forward indefinitely. At December 31, 2021, the Company had state NOL carryforwards available of $32,869 to offset future taxable income. A portion of the state NOLs will expire between 2030 and 2042 and $22,706 can be carried forward indefinitely. The Company had federal general business credits of $3,578 at December 21, 2021, which can be carried forward for 20 years and if unused, will expire between 2037 and 2041.

The Company had deferred tax assets related to federal and state net operating loss carryforwards. When determining the need for a valuation allowance, the Company considers all available positive and negative evidence, including taxable income in prior carryback years (if carryback is permitted under the relevant tax law), the timing of the reversal of existing taxable temporary differences, tax planning strategies and projected future taxable income. The Company adjusts the valuation allowance in the period management determines it is more likely than not that the Company will not realize some or all of the deferred tax assets.

For financial reporting purposes, the Company established valuation allowances of $122 and $0 at December 31, 2021 and 2020, respectively, to offset deferred tax assets relating primarily to state net operating losses.

The income tax benefit recorded in 2021 is different from the expected statutory federal and state tax benefit primarily due to a $12,494 income tax benefit related to stock option exercises, which is net of the impact of the internal revenue code rules and regulations related to the deductibility of executive compensation by publicly held companies.

On March 27, 2020, Congress enacted the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act. The CARES Act permitted NOLs from the 2018, 2019 and 2020 tax years to be carried back to the previous 5 tax years and also enabled taxpayers to offset 100% of taxable income with available NOLs, through the 2020 tax year. During 2020, the Company carried back its 2018 NOL resulting in the refund of $9,748 of taxes paid in prior years. The carryback produced an income tax benefit of $3,906 from the difference between the currently enacted tax rate of 21% applicable if the NOL were carried forward and the higher rate applicable to the Company’s 2015, 2016 and 2017 tax years to which it was carried back.

The CARES Act also favorably adjusted a provision from the Tax Cuts and Jobs Act that was enacted in late 2017. Beginning in 2018, Section 163(j) limited the deduction of interest expense in excess of interest income plus 30% of a company’s taxable earnings before interest, depreciation, amortization, and income taxes. Any such nondeductible amount is carried forward indefinitely and used in a year in which a company no longer has excess interest expense. The CARES Act adjusted the 30% threshold to 50% for the 2019 and 2020 tax years. As of December 31, 2021, the Company had federal and state excess interest expense carry forwards, tax effected, of $0 and $498, respectively.

Past ownership changes and other equity transactions may have triggered Sections 382 and 383 of the Internal Revenue Code, resulting in certain annual limitations on the utilization of existing federal and state net operating losses and credits. Such provisions may limit the potential future tax benefit to be realized by the Company from its accumulated net operating losses and tax credit carryforwards.

The Company files income tax returns in the U.S. federal and various state tax jurisdictions and is subject to varying statutes of limitation in each jurisdiction. As of December 31, 2021, the Company is not under audit for federal or state income tax purposes. In general, the Company’s federal tax return may be subject to examination for the 2018 through 2020 tax years, while for state purposes, the 2017 through 2020 years are generally open to examination, with some states having either a three- or four-year statute of limitations. The Company’s usage of NOL carryovers also permits taxing authorities to adjust aspects of tax returns that may be outside of these statutes of limitation.

The Company’s policy is to recognize interest and penalties related to income tax matters in income tax (benefit) provision. The Company neither accrued for nor recognized any interest or penalties in income tax expense as of December 31, 2021 or 2020. The Company has not accrued for any uncertain tax positions as of December 31, 2021 or 2020 and believes that it is unlikely that there will be a significant increase or decrease of any unrecognized tax benefits within the next twelve months.